PharmaShots | Incisive News in 3 Shots

Subscribe Now

Topical

Incyte's Opzelura (ruxolitinib) Receives the US FDA's Approval for the Treatment of Atopic Dermatitis

Incyte's Opzelura (ruxolitinib) Receives the US FDA's Approval for the Treatment of Atopic Dermatitis

September 22, 2021

MatriSys Report Results of MSB-0221 in P-I study for the Topical Treatment of Atopic Dermatitis

MatriSys Report Results of MSB-0221 in P-I study for the Topical Treatment of Atopic Dermatitis

February 23, 2021

Bausch's Duobrii (Halobetasol Propionate and Tazarotene) Receives FDA's Approval for Topical Treatment of Plaque Psoriasis in Adults

Bausch's Duobrii (Halobetasol Propionate and Tazarotene) Receives FDA's Approval for Topical Treatment of Plaque Psoriasis in Adul...

April 25, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us